Impact of Disease History on the Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

Main Article Content

Brett King
Wilma Bergfeld
Pawel Brzewski
Özge Aşkin
Thierry Passeron
Simaran Randhawa
Ernest Law
Roger A Edwards
Robert Wolk
Samuel H Zwillich
Alexandre Lejeune

Keywords

alopecia areata, efficacy, ritlecitinib, ALLEGRO, clinical trial

References

1. Islam N, et al. Autoimmun Rev. 2015;14:81-89

2. King B, et al. Poster presented at: 30th Annual EADV Meeting; September 29-October 2, 2021

3. Liu LY, et al. JAAD. 2017;76:22-28

4. King BA, et al. JAAD. 2022;86:359-364

5. Meah N, et al. JAAD. 2021;84:1594-1601.

Most read articles by the same author(s)